Publication | Open Access
Low‐dose azacitidine after allogeneic stem cell transplantation for acute leukemia
197
Citations
25
References
2009
Year
: Low-dose 5-azacitidine may induce durable remissions for patients who develop disease recurrence after HSCT. Further follow-up and a larger group of patients will be necessary to confirm these observations. Cancer 2009. (c) 2009 American Cancer Society.
| Year | Citations | |
|---|---|---|
Page 1
Page 1